Literature DB >> 27019568

Proteomics Analysis of Brain Meningiomas in Pursuit of Novel Biomarkers of the Aggressive Behavior.

Garni Barkhoudarian, Julian P Whitelegge, Daniel F Kelly, Margaret Simonian.   

Abstract

The aim of this pilot study was to evaluate the use of advanced proteomics techniques to identify novel protein markers that contribute to the transformation of benign meningiomas to more aggressive and malignant subtypes. Multiplex peptide stable isotope dimethyl labelling and nano-LCMS was used to identify and quantify the differentially expressed proteins in WHO Grade I, II and III meningioma tissues. The proteins identified will help elucidate the process of transformation to malignancy and may contribute to improved diagnosis and treatment of these aggressive tumors.

Entities:  

Keywords:  Anaplastic meningioma; Atypical meningioma; Biomarkers; Meningioma; Proteomics

Year:  2016        PMID： 27019568      PMCID： PMC4807620          DOI： 10.4172/jpb.1000389

Source DB:  PubMed          Journal:  J Proteomics Bioinform        ISSN： 0974-276X


  15 in total

Review 1.  Clinical proteomics: translating benchside promise into bedside reality.

Authors:  Emanuel F Petricoin; Kathryn C Zoon; Elise C Kohn; J Carl Barrett; Lance A Liotta
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

2.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

Review 3.  Proteomic applications for the early detection of cancer.

Authors:  Julia D Wulfkuhle; Lance A Liotta; Emanuel F Petricoin
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

4.  Comparative proteomic profiles of meningioma subtypes.

Authors:  Hiroaki Okamoto; Jie Li; Alexander O Vortmeyer; Howard Jaffe; Youn-Soo Lee; Sven Gläsker; Tae-Sung Sohn; Weifen Zeng; Barbara Ikejiri; Martin A Proescholdt; Christina Mayer; Robert J Weil; Edward H Oldfield; Zhengping Zhuang
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

5.  Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis.

Authors:  Connie G Chiu; Yoshitaka Nakamura; Kelly K Chong; Sharon K Huang; Neal P Kawas; Timothy Triche; David Elashoff; Eiji Kiyohara; Reiko F Irie; Donald L Morton; Dave S B Hoon
Journal:  Clin Chem       Date:  2014-04-09       Impact factor: 8.327

6.  Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.

Authors:  Soichi Oya; Kensuke Kawai; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Neurosurg       Date:  2012-05-04       Impact factor: 5.115

7.  High throughput screening of meningioma biomarkers using a tissue microarray.

Authors:  Eriks A Lusis; Michael R Chicoine; Arie Perry
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

Review 8.  The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.

Authors:  Winward Choy; Won Kim; Daniel Nagasawa; Stephanie Stramotas; Andrew Yew; Quinton Gopen; Andrew T Parsa; Isaac Yang
Journal:  Neurosurg Focus       Date:  2011-05       Impact factor: 4.047

9.  Simpson grade: an opportunity to reassess the need for complete resection of meningiomas.

Authors:  James Barry Heald; Thomas Anthony Carroll; Richard James Mair
Journal:  Acta Neurochir (Wien)       Date:  2013-11-06       Impact factor: 2.216

10.  [Therapeutic results of the treatment brain tumors using radiosurgery and stereotactic radiotherapy].

Authors:  H Doleželová; L Hynková; P Pospíšil; T Kazda; P Slampa; I Coupková; I Siková; P Fardus; T Svoboda; J Garčic; M Vrzal; I Selingerová; I Horová
Journal:  Klin Onkol       Date:  2012
View more
  10 in total

1.  Evaluation of autoantibody signatures in meningioma patients using human proteome arrays.

Authors:  Shabarni Gupta; Shuvolina Mukherjee; Parvez Syed; Narendra Goud Pandala; Saket Choudhary; Vedita Anand Singh; Namrata Singh; Heng Zhu; Sridhar Epari; Santosh B Noronha; Aliasgar Moiyadi; Sanjeeva Srivastava
Journal:  Oncotarget       Date:  2017-04-10

2.  Histological transformation in recurrent WHO grade I meningiomas.

Authors:  Marco V Corniola; Jean-Michel Lemée; Torstein R Meling
Journal:  Sci Rep       Date:  2020-07-08       Impact factor: 4.379

3.  Molecular changes tracking through multiscale fluorescence microscopy differentiate Meningioma grades and non-tumoral brain tissues.

Authors:  Hussein Mehidine; Matthieu Refregiers; Frédéric Jamme; Pascale Varlet; Marjorie Juchaux; Bertrand Devaux; Darine Abi Haidar
Journal:  Sci Rep       Date:  2021-02-15       Impact factor: 4.379

4.  Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies.

Authors:  Ahmad A Nazem; Jacob Ruzevick; Manuel J Ferreira
Journal:  Oncotarget       Date:  2020-12-08

5.  Proteogenomics for pediatric brain cancer.

Authors:  Margaret Simonian
Journal:  Biocell       Date:  2021-09-01       Impact factor: 1.254

Review 6.  Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma.

Authors:  Rafael Roesler; Barbara Kunzler Souza; Gustavo R Isolan
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 7.  Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives.

Authors:  Hajime Takase; Tetsuya Yamamoto
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

8.  Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression.

Authors:  Carolina Angelica Parada; Joshua Osbun; Sumanpreet Kaur; Youssef Yakkioui; Min Shi; Catherine Pan; Tina Busald; Yigit Karasozen; Luis Francisco Gonzalez-Cuyar; Robert Rostomily; Jing Zhang; Manuel Ferreira
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

9.  Comparative Proteomic Analysis of Tumor Mesenchymal-Like Stem Cells Derived from High Grade versus Low Grade Gliomas.

Authors:  Mousa Taghipour; Aydine Omidvar; Mahboobeh Razmkhah; Abbas Ghaderi; Zahra Mojtahedi
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

Review 10.  Multi-Omics Analysis in Initiation and Progression of Meningiomas: From Pathogenesis to Diagnosis.

Authors:  Jiachen Liu; Congcong Xia; Gaiqing Wang
Journal:  Front Oncol       Date:  2020-08-28       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.